JP2020055849A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020055849A5 JP2020055849A5 JP2019220807A JP2019220807A JP2020055849A5 JP 2020055849 A5 JP2020055849 A5 JP 2020055849A5 JP 2019220807 A JP2019220807 A JP 2019220807A JP 2019220807 A JP2019220807 A JP 2019220807A JP 2020055849 A5 JP2020055849 A5 JP 2020055849A5
- Authority
- JP
- Japan
- Prior art keywords
- tau
- binding
- seq
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022105415A JP7413448B2 (ja) | 2015-07-06 | 2022-06-30 | Ｔａｕ結合抗体 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15175522 | 2015-07-06 | ||
| EP15175522.0 | 2015-07-06 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018500423A Division JP6630426B2 (ja) | 2015-07-06 | 2016-07-05 | Ｔａｕ結合抗体 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022105415A Division JP7413448B2 (ja) | 2015-07-06 | 2022-06-30 | Ｔａｕ結合抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020055849A JP2020055849A (ja) | 2020-04-09 |
| JP2020055849A5 true JP2020055849A5 (https=) | 2020-07-02 |
| JP7100008B2 JP7100008B2 (ja) | 2022-07-12 |
Family
ID=53524640
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018500423A Active JP6630426B2 (ja) | 2015-07-06 | 2016-07-05 | Ｔａｕ結合抗体 |
| JP2019220807A Active JP7100008B2 (ja) | 2015-07-06 | 2019-12-06 | Ｔａｕ結合抗体 |
| JP2022105415A Active JP7413448B2 (ja) | 2015-07-06 | 2022-06-30 | Ｔａｕ結合抗体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018500423A Active JP6630426B2 (ja) | 2015-07-06 | 2016-07-05 | Ｔａｕ結合抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022105415A Active JP7413448B2 (ja) | 2015-07-06 | 2022-06-30 | Ｔａｕ結合抗体 |
Country Status (29)
| Country | Link |
|---|---|
| US (4) | US10287343B2 (https=) |
| EP (2) | EP3319983B1 (https=) |
| JP (3) | JP6630426B2 (https=) |
| KR (2) | KR102770650B1 (https=) |
| CN (1) | CN107849104B (https=) |
| AR (1) | AR105267A1 (https=) |
| AU (1) | AU2016289755C1 (https=) |
| CA (1) | CA2991451A1 (https=) |
| CL (1) | CL2018000043A1 (https=) |
| CO (1) | CO2017012971A2 (https=) |
| EA (1) | EA037092B1 (https=) |
| EC (1) | ECSP18000887A (https=) |
| ES (1) | ES3060419T3 (https=) |
| HR (1) | HRP20260348T1 (https=) |
| IL (1) | IL256685B (https=) |
| MA (2) | MA41670A1 (https=) |
| MD (1) | MD3319983T2 (https=) |
| MX (1) | MX2017015817A (https=) |
| MY (1) | MY193677A (https=) |
| PE (1) | PE20180481A1 (https=) |
| PH (1) | PH12017502207B1 (https=) |
| SG (1) | SG10202010735PA (https=) |
| SM (1) | SMT202600068T1 (https=) |
| TN (1) | TN2017000539A1 (https=) |
| TW (1) | TWI745295B (https=) |
| UA (1) | UA124616C2 (https=) |
| UY (1) | UY36773A (https=) |
| WO (1) | WO2017005734A1 (https=) |
| ZA (1) | ZA201800027B (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ775762A (en) | 2015-06-05 | 2025-02-28 | Genentech Inc | Anti-tau antibodies and methods of use |
| WO2017005734A1 (en) | 2015-07-06 | 2017-01-12 | Ucb Biopharma Sprl | Tau-binding antibodies |
| US10344081B2 (en) | 2015-07-06 | 2019-07-09 | Ucb Biopharma Sprl | Tau-binding antibodies |
| MX2019006330A (es) | 2016-12-07 | 2019-09-26 | Genentech Inc | Anticuerpos anti-tau y metodos de uso. |
| UA128383C2 (uk) | 2016-12-07 | 2024-07-03 | Дженентек, Інк. | Антитіло до тау-білка та спосіб його застосування |
| WO2018119142A1 (en) | 2016-12-21 | 2018-06-28 | Amgen Inc. | Anti-tnf alpha antibody formulations |
| SG11201907422RA (en) | 2017-02-17 | 2019-09-27 | Denali Therapeutics Inc | Anti-tau antibodies and methods of use thereof |
| JP2018139530A (ja) | 2017-02-27 | 2018-09-13 | 帝人ファーマ株式会社 | 認知症治療又は予防のためのヒト化抗体及びその製造方法、並びにそれを用いた認知症治療剤又は予防剤 |
| AU2018352308B2 (en) | 2017-10-16 | 2025-06-05 | Eisai R&D Management Co., Ltd. | Anti-tau antibodies and uses thereof |
| EP3894438A1 (en) * | 2018-12-13 | 2021-10-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | New anti tau svqivykpv epitope single domain antibody |
| KR20220062287A (ko) * | 2019-08-13 | 2022-05-16 | 워싱턴 유니버시티 | Mtbr 타우 아이소폼 검출 방법 및 이의 용도 |
| CN115335406B (zh) | 2020-02-12 | 2026-01-30 | 伊莱利利公司 | 抗体或抗原-结合片段的结晶 |
| CA3183835A1 (en) | 2020-06-25 | 2021-12-30 | Jeanne E. Baker | High affinity antibodies targeting tau phosphorylated at serine 413 |
| US20250034559A1 (en) | 2021-11-17 | 2025-01-30 | Voyager Therapeutics, Inc. | Compositions and methods for the treatment of tau-related disorders |
| KR20250069606A (ko) | 2022-09-15 | 2025-05-19 | 보이저 테라퓨틱스, 인크. | 타우 결합 화합물 |
| EP4619416A1 (en) * | 2022-11-14 | 2025-09-24 | Washington University | Methods to detect csf mtbr-tau and uses thereof |
| WO2025122634A1 (en) | 2023-12-05 | 2025-06-12 | Voyager Therapeutics, Inc. | Compositions and methods for the treatment of tau-related disorders |
| WO2025171285A1 (en) * | 2024-02-09 | 2025-08-14 | University Of Notre Dame Du Lac | Tau proteomimetics |
| WO2025196217A1 (en) | 2024-03-21 | 2025-09-25 | UCB Biopharma SRL | Treatment of tauopathies with tau-binding antibodies |
| WO2026057816A1 (en) | 2024-09-13 | 2026-03-19 | UCB Biopharma SRL | Treatment of tauopathies with tau-binding antibodies |
Family Cites Families (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4741900A (en) | 1982-11-16 | 1988-05-03 | Cytogen Corporation | Antibody-metal ion complexes |
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| DK336987D0 (da) | 1987-07-01 | 1987-07-01 | Novo Industri As | Immobiliseringsmetode |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| GB8719042D0 (en) | 1987-08-12 | 1987-09-16 | Parker D | Conjugate compounds |
| GB8720833D0 (en) | 1987-09-04 | 1987-10-14 | Celltech Ltd | Recombinant dna product |
| GB8907617D0 (en) | 1989-04-05 | 1989-05-17 | Celltech Ltd | Drug delivery system |
| GB8928874D0 (en) | 1989-12-21 | 1990-02-28 | Celltech Ltd | Humanised antibodies |
| EP0519596B1 (en) | 1991-05-17 | 2005-02-23 | Merck & Co. Inc. | A method for reducing the immunogenicity of antibody variable domains |
| GB9112536D0 (en) | 1991-06-11 | 1991-07-31 | Celltech Ltd | Chemical compounds |
| GB9120467D0 (en) | 1991-09-26 | 1991-11-06 | Celltech Ltd | Anti-hmfg antibodies and process for their production |
| FR2716640B1 (fr) | 1994-02-28 | 1996-05-03 | Procedes Machines Speciales | Dispositif de centrage et de blocage d'une pièce en vue de son rodage à l'aide d'un rodoir à expansion. |
| US6372716B1 (en) | 1994-04-26 | 2002-04-16 | Genetics Institute, Inc. | Formulations for factor IX |
| US6685940B2 (en) | 1995-07-27 | 2004-02-03 | Genentech, Inc. | Protein formulation |
| GB9625640D0 (en) | 1996-12-10 | 1997-01-29 | Celltech Therapeutics Ltd | Biological products |
| US6566329B1 (en) | 1999-06-28 | 2003-05-20 | Novo Nordisk A/S | Freeze-dried preparation of human growth hormone |
| AT500379B8 (de) | 2001-02-02 | 2009-08-15 | Axon Neuroscience | Tau-proteine |
| US6908963B2 (en) | 2001-10-09 | 2005-06-21 | Nektar Therapeutics Al, Corporation | Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide therewith |
| ES2551439T5 (es) | 2003-07-01 | 2018-11-08 | Ucb Biopharma Sprl | Fragmentos Fab de anticuerpos modificados |
| GB0315457D0 (en) | 2003-07-01 | 2003-08-06 | Celltech R&D Ltd | Biological products |
| GB0315450D0 (en) | 2003-07-01 | 2003-08-06 | Celltech R&D Ltd | Biological products |
| GB0411186D0 (en) | 2004-05-19 | 2004-06-23 | Celltech R&D Ltd | Biological products |
| GB0412181D0 (en) | 2004-06-01 | 2004-06-30 | Celltech R&D Ltd | Biological products |
| CN1721437A (zh) * | 2004-07-13 | 2006-01-18 | 中南大学 | 一种与Tau蛋白相关的多肽抗原及抗体 |
| NZ612578A (en) | 2005-08-19 | 2014-11-28 | Abbvie Inc | Dual variable domain immunoglobin and uses thereof |
| GB0614780D0 (en) | 2006-07-25 | 2006-09-06 | Ucb Sa | Biological products |
| GB0619291D0 (en) | 2006-09-29 | 2006-11-08 | Ucb Sa | Altered antibodies |
| GB0624500D0 (en) * | 2006-12-07 | 2007-01-17 | Istituto Superiore Di Sanito | A novel passive vaccine for candida infections |
| EP2535349A1 (en) | 2007-09-26 | 2012-12-19 | UCB Pharma S.A. | Dual specificity antibody fusions |
| CN101307108B (zh) * | 2008-06-25 | 2012-04-04 | 南京川博生物技术有限公司 | 抗磷酸化Tau蛋白抗体及其在AD症异常磷酸化Tau蛋白水平测定上的用途 |
| CA2737241C (en) | 2008-09-26 | 2017-08-29 | Ucb Pharma S.A. | Multivalent antibody fusion proteins |
| CA2740316A1 (en) | 2008-10-15 | 2010-04-22 | Angiochem Inc. | Conjugates of glp-1 agonists and uses thereof |
| EP2370472A4 (en) | 2008-12-05 | 2013-04-24 | Angiochem Inc | LEPTIN AND LEPTIN ANALOGUE CONJUGATES AND ITS USES |
| CA2745524C (en) | 2008-12-05 | 2020-06-09 | Angiochem Inc. | Conjugates of neurotensin or neurotensin analogs and uses thereof |
| US8609097B2 (en) | 2009-06-10 | 2013-12-17 | Hoffmann-La Roche Inc. | Use of an anti-Tau pS422 antibody for the treatment of brain diseases |
| WO2011030107A1 (en) | 2009-09-10 | 2011-03-17 | Ucb Pharma S.A. | Multivalent antibodies |
| AU2010305284A1 (en) | 2009-10-06 | 2012-05-03 | Angiochem Inc. | Compositions and methods for the transport of therapeutic agents |
| MY164376A (en) | 2010-10-07 | 2017-12-15 | Univ Leuven Kath | Phosphospecific antibodies recognizing tau |
| CA2813493C (en) * | 2010-10-11 | 2019-07-09 | University Of Zurich | Human anti-tau antibodies |
| JOP20210044A1 (ar) | 2010-12-30 | 2017-06-16 | Takeda Pharmaceuticals Co | الأجسام المضادة لـ cd38 |
| ME03008B (me) | 2011-09-19 | 2018-10-20 | Axon Neuroscience Se | Terapija na osnovu proteina i dijagnoza patologije u којој posreduje tau u alcнajмerovoj bolesti |
| US20140294724A1 (en) * | 2011-10-24 | 2014-10-02 | Intellect Neurosciences, Inc. | Compositions and methods for treatment of proteinopathies |
| WO2013068571A1 (en) | 2011-11-11 | 2013-05-16 | Ucb Pharma S.A. | Albumin binding antibodies and binding fragments thereof |
| MX350311B (es) | 2011-12-20 | 2017-09-01 | Janssen Biotech Inc | Anticuerpos anti-phf-tau y sus usos. |
| SG10201708959WA (en) * | 2012-07-03 | 2017-11-29 | Univ Washington | Antibodies to tau |
| NZ630542A (en) * | 2012-08-16 | 2017-06-30 | Ipierian Inc | Methods of treating a tauopathy |
| CA2896066C (en) | 2012-12-21 | 2022-07-12 | Biogen Ma Inc. | Human anti-tau antibodies |
| CA2874083C (en) * | 2014-12-05 | 2024-01-02 | Universite Laval | Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases |
| US10344081B2 (en) | 2015-07-06 | 2019-07-09 | Ucb Biopharma Sprl | Tau-binding antibodies |
| WO2017005734A1 (en) | 2015-07-06 | 2017-01-12 | Ucb Biopharma Sprl | Tau-binding antibodies |
-
2016
- 2016-07-05 WO PCT/EP2016/065813 patent/WO2017005734A1/en not_active Ceased
- 2016-07-05 EP EP16734676.6A patent/EP3319983B1/en active Active
- 2016-07-05 UA UAA201711739A patent/UA124616C2/uk unknown
- 2016-07-05 AU AU2016289755A patent/AU2016289755C1/en active Active
- 2016-07-05 MD MDE20180496T patent/MD3319983T2/ro unknown
- 2016-07-05 EP EP25223812.6A patent/EP4729538A2/en active Pending
- 2016-07-05 KR KR1020187003689A patent/KR102770650B1/ko active Active
- 2016-07-05 MA MA41670A patent/MA41670A1/fr unknown
- 2016-07-05 SG SG10202010735PA patent/SG10202010735PA/en unknown
- 2016-07-05 JP JP2018500423A patent/JP6630426B2/ja active Active
- 2016-07-05 US US15/742,087 patent/US10287343B2/en active Active
- 2016-07-05 SM SM20260068T patent/SMT202600068T1/it unknown
- 2016-07-05 PH PH1/2017/502207A patent/PH12017502207B1/en unknown
- 2016-07-05 HR HRP20260348TT patent/HRP20260348T1/hr unknown
- 2016-07-05 CN CN201680039795.4A patent/CN107849104B/zh active Active
- 2016-07-05 EA EA201890172A patent/EA037092B1/ru not_active IP Right Cessation
- 2016-07-05 MA MA042377A patent/MA42377A/fr unknown
- 2016-07-05 KR KR1020257004988A patent/KR20250027278A/ko active Pending
- 2016-07-05 MY MYPI2018700043A patent/MY193677A/en unknown
- 2016-07-05 MX MX2017015817A patent/MX2017015817A/es unknown
- 2016-07-05 TN TNP/2017/000539A patent/TN2017000539A1/en unknown
- 2016-07-05 ES ES16734676T patent/ES3060419T3/es active Active
- 2016-07-05 PE PE2017002750A patent/PE20180481A1/es unknown
- 2016-07-05 CA CA2991451A patent/CA2991451A1/en active Pending
- 2016-07-06 TW TW105121455A patent/TWI745295B/zh active
- 2016-07-06 UY UY0001036773A patent/UY36773A/es not_active Application Discontinuation
- 2016-07-06 AR ARP160102045A patent/AR105267A1/es unknown
-
2017
- 2017-12-18 CO CONC2017/0012971A patent/CO2017012971A2/es unknown
-
2018
- 2018-01-01 IL IL256685A patent/IL256685B/en unknown
- 2018-01-03 ZA ZA2018/00027A patent/ZA201800027B/en unknown
- 2018-01-05 CL CL2018000043A patent/CL2018000043A1/es unknown
- 2018-01-05 EC ECIEPI2018887A patent/ECSP18000887A/es unknown
-
2019
- 2019-05-13 US US16/409,945 patent/US10889640B2/en active Active
- 2019-12-06 JP JP2019220807A patent/JP7100008B2/ja active Active
-
2020
- 2020-12-29 US US17/136,189 patent/US11732034B2/en active Active
-
2022
- 2022-06-30 JP JP2022105415A patent/JP7413448B2/ja active Active
-
2023
- 2023-06-30 US US18/344,945 patent/US20230416350A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020055849A5 (https=) | ||
| JP2019122405A5 (https=) | ||
| JP2020039360A5 (https=) | ||
| JP2022519118A5 (https=) | ||
| JP2016513682A5 (https=) | ||
| JP2016512551A5 (https=) | ||
| JP2019522961A5 (https=) | ||
| JP2017113028A5 (https=) | ||
| JP2013198490A5 (https=) | ||
| JP2020508655A5 (https=) | ||
| RU2015136078A (ru) | Антитело против с5 и способ предупреждения и лечения обусловленных комплементом заболеваний | |
| JP2019504032A5 (https=) | ||
| JP2020514277A5 (https=) | ||
| JP2018516853A5 (https=) | ||
| JP2020504101A5 (https=) | ||
| JP2017052784A5 (https=) | ||
| RU2016125489A (ru) | Нейтрализующие моноклональные человеческие антитела против интерлейкина-33 | |
| JP2017528476A5 (https=) | ||
| RU2017125758A (ru) | Антитела к с5 и способы их применения | |
| JP2012502649A5 (https=) | ||
| JP2023551027A5 (https=) | ||
| JP2016533763A5 (ja) | ヒトｐｄ−１に特異的に結合する抗体抗原結合ドメインおよびそれを含む医薬組成物 | |
| JP2018510617A5 (https=) | ||
| RU2017134495A (ru) | Антитела к альфа-рецептору собачьего интерлейкина-4 | |
| RU2017128882A (ru) | Антитела к биотину и способы их применения |